May 5 (Reuters) - IRLAB Therapeutics AB IRLABa.ST:
IRLAB RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK 68 MILLION WITH AN OVERALLOTMENT ISSUE AND OBTAINS EXTENDED LOAN FINANCING
EXTENDS SEK 18.5 MILLION OF SEK 23.7 MILLION LOAN FROM FENJA CAPITAL TO NOV 30, 2027
EXTRAORDINARY GENERAL MEETING TO APPROVE RIGHTS ISSUE AND OVERALLOTMENT ISSUE ON JUNE 5, 2026
BOARD RESOLVES ON OVERALLOTMENT ISSUE OF UP TO ABOUT SEK 33.8 MILLION
Source text: ID:nMFNRLdgF
Further company coverage: [IRLABa.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))